Skip to main navigation Skip to search Skip to main content

Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator

  • Takayuki Sumiyoshi
  • , Kenichi Iijima
  • , Shinya Fujiki
  • , Koji Hirabayashi
  • , Hiroki Matsumoto
  • , Shunsuke Kuroda
  • , Hidemori Hayashi
  • , Yoshihisa Nakagawa
  • , Kazuyoshi Takahashi
  • , Masaaki Okabe
  • , Kengo Kusano
  • , Shingen Owada
  • , Yusuke Kondo
  • , Kenichi Tsujita
  • , Yoshiaki Kubota
  • , Hirofumi Tomita
  • , Toshihisa Anzai
  • , Morio Shoda
  • , Masafumi Watanabe
  • , Takashi Tokano
  • Toyoaki Murohara, Takashi Kaneshiro, Takeshi Kato, Hidehira Fukaya, Koji Maemura, Tomio Umemoto, Ritsushi Katou, Takashi Saigawa, Shigeto Naito, Kenji Ando, Masafumi Yano, Junichi Nitta, Tetsuji Miura, Yugo Yamashita, Kazuomi Kario, Miyako Igarashi, Hisako Yoshida, Takahiro Tanaka, Koichi Node, Tohru Minamino

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1343-1346
Number of pages4
JournalCirculation
Volume153
Issue number17
DOIs
StatePublished - 28 Apr 2026
Externally publishedYes

Keywords

  • cardiography, impedance
  • defibrillators, implantable
  • heart failure
  • sodium-glucose transporter 2 inhibitors

Cite this